{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:13:40Z","timestamp":1765808020510,"version":"3.48.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-025-01229-3","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:54:57Z","timestamp":1765806897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiple sclerosis risk stratification and healthcare cost prediction using machine learning"],"prefix":"10.1038","volume":"5","author":[{"given":"Lukasz S.","family":"Wylezinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamieson D.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9015-6321","authenticated-orcid":false,"suffix":"III","given":"Charles F.","family":"Spurlock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"1229_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nrneurol.2017.171","volume":"14","author":"C Tur","year":"2018","unstructured":"Tur, C. et al. Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting. Nat. Rev. Neurol. 14, 75\u201393 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"1229_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s13311-012-0160-7","volume":"10","author":"R Berkovich","year":"2013","unstructured":"Berkovich, R. Treatment of acute relapses in multiple sclerosis. Neurotherapeutics 10, 97\u2013105 (2013).","journal-title":"Neurotherapeutics"},{"key":"1229_CR3","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/S0140-6736(16)30959-X","volume":"389","author":"WJ Brownlee","year":"2017","unstructured":"Brownlee, W. J., Hardy, T. A., Fazekas, F. & Miller, D. H. Diagnosis of multiple sclerosis: progress and challenges. Lancet 389, 1336\u20131346 (2017).","journal-title":"Lancet"},{"key":"1229_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162\u2013173 (2018).","journal-title":"Lancet Neurol."},{"key":"1229_CR5","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3389\/fneur.2020.00851","volume":"11","author":"M Magyari","year":"2020","unstructured":"Magyari, M. & Sorensen, P. S. Comorbidity in multiple sclerosis. Front. Neurol. 11, 851 (2020).","journal-title":"Front. Neurol."},{"key":"1229_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1243589","volume":"14","author":"JJ Marriott","year":"2023","unstructured":"Marriott, J. J., Ekuma, O., Fransoo, R. & Marrie, R. A. Switching to second line MS disease-modifying therapies is associated with decreased relapse rate. Front. Neurol. 14, 1243589 (2023).","journal-title":"Front. Neurol."},{"key":"1229_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","volume":"22","author":"T Kuhlmann","year":"2023","unstructured":"Kuhlmann, T. et al. Multiple sclerosis progression: time for a new mechanism-driven framework. Lancet Neurol. 22, 78\u201388 (2023).","journal-title":"Lancet Neurol."},{"key":"1229_CR8","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s12325-019-01186-z","volume":"37","author":"P Mankinen","year":"2020","unstructured":"Mankinen, P. et al. Cost assessment modelling of treatments for highly active relapsing multiple sclerosis. Adv. Ther. 37, 800\u2013818 (2020).","journal-title":"Adv. Ther."},{"key":"1229_CR9","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/1352458518807082","volume":"25","author":"P Soelberg Sorensen","year":"2019","unstructured":"Soelberg Sorensen, P. et al. The multiple sclerosis care unit. Mult. Scler. 25, 627\u2013636 (2019).","journal-title":"Mult. Scler."},{"key":"1229_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jns.2013.04.007","volume":"330","author":"H Paris\u00e9","year":"2013","unstructured":"Paris\u00e9, H. et al. Direct and indirect cost burden associated with multiple sclerosis relapses: excess costs of persons with MS and their spouse caregivers. J. Neurol. Sci. 330, 71\u201377 (2013).","journal-title":"J. Neurol. Sci."},{"key":"1229_CR11","first-page":"1354","volume":"29","author":"M Schauf","year":"2023","unstructured":"Schauf, M., Chinthapatla, H., Dimri, S., Li, E. & Hartung, D. M. Economic burden of multiple sclerosis in the United States: a systematic literature review. J. Manag Care Spec. Pharm. 29, 1354\u20131368 (2023).","journal-title":"J. Manag Care Spec. Pharm."},{"key":"1229_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/eurpub\/ckz168","volume":"29","author":"R Pastorino","year":"2019","unstructured":"Pastorino, R. et al. Benefits and challenges of Big Data in healthcare: an overview of the European initiatives. Eur. J. Public Health 29, 23\u201327 (2019).","journal-title":"Eur. J. Public Health"},{"key":"1229_CR13","doi-asserted-by":"publisher","first-page":"e288","DOI":"10.1016\/S2589-7500(23)00025-0","volume":"5","author":"IRI Alberto","year":"2023","unstructured":"Alberto, I. R. I. et al. The impact of commercial health datasets on medical research and health-care algorithms. Lancet Digit Health 5, e288\u2013e294 (2023).","journal-title":"Lancet Digit Health"},{"key":"1229_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11606-021-06896-1","volume":"37","author":"BC Ricci","year":"2022","unstructured":"Ricci, B. C., Sachs, J., Dobbertin, K., Khan, F. & Dorr, D. A. Risk stratification in primary care: value-based contributions of provider adjudication. J. Gen. Intern. Med. 37, 601\u2013607 (2022).","journal-title":"J. Gen. Intern. Med."},{"key":"1229_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2047-2501-2-3","volume":"2","author":"W Raghupathi","year":"2014","unstructured":"Raghupathi, W. & Raghupathi, V. Big data analytics in healthcare: promise and potential. Health Inf. Sci. Syst. 2, 3 (2014).","journal-title":"Health Inf. Sci. Syst."},{"key":"1229_CR16","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3414\/ME15-06-1001","volume":"54","author":"SS Tan","year":"2015","unstructured":"Tan, S. S., Gao, G. & Koch, S. Big data and analytics in healthcare. Methods Inf. Med. 54, 546\u2013547 (2015).","journal-title":"Methods Inf. Med."},{"key":"1229_CR17","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/s41551-022-00898-y","volume":"6","author":"A Zhang","year":"2022","unstructured":"Zhang, A., Xing, L., Zou, J. & Wu, J. C. Shifting machine learning for healthcare from development to deployment and from models to data. Nat. Biomed. Eng. 6, 1330\u20131345 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"1229_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12909-023-04698-z","volume":"23","author":"SA Alowais","year":"2023","unstructured":"Alowais, S. A. et al. Revolutionizing healthcare: the role of artificial intelligence in clinical practice. BMC Med. Educ. 23, 689 (2023).","journal-title":"BMC Med. Educ."},{"key":"1229_CR19","doi-asserted-by":"publisher","first-page":"8459","DOI":"10.1007\/s12652-021-03612-z","volume":"14","author":"Y Kumar","year":"2023","unstructured":"Kumar, Y., Koul, A., Singla, R. & Ijaz, M. F. Artificial intelligence in disease diagnosis: a systematic literature review, synthesizing framework and future research agenda. J. Ambient Intell. Humaniz Comput 14, 8459\u20138486 (2023).","journal-title":"J. Ambient Intell. Humaniz Comput"},{"key":"1229_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1370\/afm.2124","volume":"15","author":"A Reddy","year":"2017","unstructured":"Reddy, A. et al. Risk stratification methods and provision of care management services in comprehensive primary care initiative practices. Ann. Fam. Med. 15, 451\u2013454 (2017).","journal-title":"Ann. Fam. Med."},{"key":"1229_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41746-020-00354-8","volume":"3","author":"I Osawa","year":"2020","unstructured":"Osawa, I., Goto, T., Yamamoto, Y. & Tsugawa, Y. Machine-learning-based prediction models for high-need high-cost patients using nationwide clinical and claims data. NPJ Digit Med. 3, 148 (2020).","journal-title":"NPJ Digit Med."},{"key":"1229_CR22","doi-asserted-by":"publisher","first-page":"e0279540","DOI":"10.1371\/journal.pone.0279540","volume":"18","author":"B Langenberger","year":"2023","unstructured":"Langenberger, B., Schulte, T. & Groene, O. The application of machine learning to predict high-cost patients: A performance-comparison of different models using healthcare claims data. PLoS One 18, e0279540 (2023).","journal-title":"PLoS One"},{"key":"1229_CR23","doi-asserted-by":"publisher","first-page":"e011580","DOI":"10.1136\/bmjopen-2016-011580","volume":"7","author":"S Tamang","year":"2017","unstructured":"Tamang, S. et al. Predicting patient \u2018cost blooms\u2019 in Denmark: a longitudinal population-based study. BMJ Open 7, e011580 (2017).","journal-title":"BMJ Open"},{"key":"1229_CR24","unstructured":"Snooks, H. et al. Predictive Risk Stratification Model: a Randomised Stepped-Wedge Trial In Primary Care (PRISMATIC). (NIHR Journals Library, 2018)."},{"key":"1229_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13561-023-00422-1","volume":"13","author":"N Nghiem","year":"2023","unstructured":"Nghiem, N., Atkinson, J., Nguyen, B. P., Tran-Duy, A. & Wilson, N. Predicting high health-cost users among people with cardiovascular disease using machine learning and nationwide linked social administrative datasets. Health Econ. Rev. 13, 9 (2023).","journal-title":"Health Econ. Rev."},{"key":"1229_CR26","doi-asserted-by":"publisher","first-page":"e0221911","DOI":"10.1371\/journal.pone.0221911","volume":"14","author":"S Suzuki","year":"2019","unstructured":"Suzuki, S. et al. Comparison of risk models for mortality and cardiovascular events between machine learning and conventional logistic regression analysis. PLoS One 14, e0221911 (2019).","journal-title":"PLoS One"},{"key":"1229_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41746-021-00426-3","volume":"4","author":"BK Beaulieu-Jones","year":"2021","unstructured":"Beaulieu-Jones, B. K. et al. Machine learning for patient risk stratification: standing on, or looking over, the shoulders of clinicians?. NPJ Digit Med. 4, 62 (2021).","journal-title":"NPJ Digit Med."},{"key":"1229_CR28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1474-4422(21)00095-8","volume":"20","author":"MP Wattjes","year":"2021","unstructured":"Wattjes, M. P. et al. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol. 20, 653\u2013670 (2021).","journal-title":"Lancet Neurol."},{"key":"1229_CR29","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jval.2019.02.012","volume":"22","author":"P Doupe","year":"2019","unstructured":"Doupe, P., Faghmous, J. & Basu, S. Machine learning for health services researchers. Value Health 22, 808\u2013815 (2019).","journal-title":"Value Health"},{"key":"1229_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20910-4","volume":"12","author":"KH Goh","year":"2021","unstructured":"Goh, K. H. et al. Artificial intelligence in sepsis early prediction and diagnosis using unstructured data in healthcare. Nat. Commun. 12, 711 (2021).","journal-title":"Nat. Commun."},{"key":"1229_CR31","first-page":"352","volume":"3","author":"JA Opara","year":"2010","unstructured":"Opara, J. A., Jaracz, K. & Brola, W. Quality of life in multiple sclerosis. J. Med. Life 3, 352\u2013358 (2010).","journal-title":"J. Med. Life"},{"key":"1229_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-022-02700-7","volume":"22","author":"Z Hosseini","year":"2022","unstructured":"Hosseini, Z., Homayuni, A. & Etemadifar, M. Barriers to quality of life in patients with multiple sclerosis: a qualitative study. BMC Neurol. 22, 174 (2022).","journal-title":"BMC Neurol."},{"key":"1229_CR33","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.2165\/00003495-200363150-00001","volume":"63","author":"P Flachenecker","year":"2003","unstructured":"Flachenecker, P. & Rieckmann, P. Early intervention in multiple sclerosis: better outcomes for patients and society?. Drugs 63, 1525\u20131533 (2003).","journal-title":"Drugs"},{"key":"1229_CR34","unstructured":"(UK) NCGC. Multiple Sclerosis: Management of Multiple Sclerosis in Primary and Secondary Care (NCGC, 2014)."},{"key":"1229_CR35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.msard.2018.09.002","volume":"26","author":"TA Nazareth","year":"2018","unstructured":"Nazareth, T. A. et al. Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey. Mult. Scler. Relat. Disord. 26, 219\u2013234 (2018).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1229_CR36","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00415-015-7986-y","volume":"263","author":"T Ziemssen","year":"2016","unstructured":"Ziemssen, T. et al. Optimizing treatment success in multiple sclerosis. J. Neurol. 263, 1053\u20131065 (2016).","journal-title":"J. Neurol."},{"key":"1229_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1356436","volume":"15","author":"J Wenk","year":"2024","unstructured":"Wenk, J., Voigt, I., Inojosa, H., Schlieter, H. & Ziemssen, T. Building digital patient pathways for the management and treatment of multiple sclerosis. Front. Immunol. 15, 1356436 (2024).","journal-title":"Front. Immunol."},{"key":"1229_CR38","doi-asserted-by":"publisher","first-page":"e899","DOI":"10.1212\/WNL.0000000000201645","volume":"100","author":"A Khakban","year":"2023","unstructured":"Khakban, A. et al. Direct health care costs associated with multiple sclerosis: a population-based cohort study in British Columbia, Canada, 2001-2020. Neurology 100, e899\u2013e910 (2023).","journal-title":"Neurology"},{"key":"1229_CR39","doi-asserted-by":"publisher","first-page":"e1810","DOI":"10.1212\/WNL.0000000000200150","volume":"98","author":"B Bebo","year":"2022","unstructured":"Bebo, B. et al. The economic burden of multiple sclerosis in the United States: estimate of direct and indirect costs. Neurology 98, e1810\u2013e1817 (2022).","journal-title":"Neurology"},{"key":"1229_CR40","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s10072-022-06517-7","volume":"44","author":"M Ponzio","year":"2023","unstructured":"Ponzio, M. et al. The economic impact of comorbidity in multiple sclerosis. Neurol. Sci. 44, 999\u20131008 (2023).","journal-title":"Neurol. Sci."},{"key":"1229_CR41","volume":"6","author":"G B\u00fctepage","year":"2020","unstructured":"B\u00fctepage, G. et al. Cost-of-illness trajectories among people with multiple sclerosis by comorbidity: a register-based prospective study in Sweden. Mult. Scler. J. Exp. Transl. Clin. 6, 2055217320968597 (2020).","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"1229_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52428-2","volume":"14","author":"K Chadaga","year":"2024","unstructured":"Chadaga, K. et al. Explainable artificial intelligence approaches for COVID-19 prognosis prediction using clinical markers. Sci. Rep. 14, 1783 (2024).","journal-title":"Sci. Rep."},{"key":"1229_CR43","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3389\/fneur.2020.00464","volume":"11","author":"K Allen-Philbey","year":"2020","unstructured":"Allen-Philbey, K. et al. Can we improve the monitoring of people with multiple sclerosis using simple tools, data sharing, and patient engagement?. Front Neurol. 11, 464 (2020).","journal-title":"Front Neurol."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01229-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01229-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01229-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:03:37Z","timestamp":1765807417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01229-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1229"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-01229-3","relation":{},"ISSN":["2730-664X"],"issn-type":[{"type":"electronic","value":"2730-664X"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.S.W., J.D.G. and C.F.S. are employed by and own stock in Decode Health. The authors declare no non-financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"524"}}